Stay updated on Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial

Sign up to get notified when there's something new on the Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3. No changes to study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-03-07T18:25:15.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2, indicating a minor template/version change and no substantive content changes detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-14T04:44:49.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Update is a minor version bump from v3.4.0 to v3.4.1 with no visible changes to study content or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-07T05:09:38.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added 'Show glossary', 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Removed 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.
    Difference
    0.2%
    Check dated 2026-01-23T23:00:35.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Footer revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-17T00:53:26.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    A Locations section has been added, listing Ontario and the Toronto, Canada site (St. Michael's Hospital). The previous Ontario Locations entry and the HHS Vulnerability Disclosure link have been removed in this revision.
    Difference
    0.2%
    Check dated 2025-12-19T16:14:31.000Z thumbnail image

Stay in the know with updates to Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Empagliflozin Effects on Cardiac Structure in T2D Clinical Trial page.